Home › Funds › Paradigm Biocapital Advisors LP › INSM

Paradigm Biocapital Advisors LP position in INSM

INSMED INC · Health Care

Paradigm Biocapital Advisors LP reported holding 2,695,977 shares of INSM (INSMED INC) in its Q3 2026 13F filing — a position valued at US$307.7M, representing 6.12% of its reported portfolio and ranking #5 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed INSM holdings in 4 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)2.70M sh
Reported value held$307.72M
Portfolio Weight6.12%
First reportedQ1 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's INSM position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in INSM in Q1 2025 at 451,359 shares (US$34.4M). The position peaked in Q3 2026 at 2,695,977 shares, worth US$307.7M. Across 4 filings, Paradigm Biocapital Advisors LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,695,977 shares valued at US$307.7M — an increase of 1,370,000 shares quarter over quarter.. Notable position changes include a 103% increase in Q3 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 451.36K $34.43M New
Q1 2026 1.25M $205.13M New
Q2 2026 1.33M $141.38M Add
Q3 2026 2.70M $307.72M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INSM and 13F data

INSM (INSMED INC) is a Health Care company. 41 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Orbis Allan Gray Ltd (US$768.6M), Darwin Global Management, Ltd. (US$673.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INSM

All INSM fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held INSM?

Paradigm Biocapital Advisors LP has disclosed INSM holdings in 4 of the last 7 reported quarters, going back to Q1 2025.

What is Paradigm Biocapital Advisors LP's current position in INSM?

As of Q3 2026, Paradigm Biocapital Advisors LP holds 2.70M shares of INSM (INSMED INC), valued at $307.72M, representing 6.12% of its reported portfolio and ranking #5.

Has Paradigm Biocapital Advisors LP been buying or selling INSM?

In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP increased its position in INSM. The position peaked in Q3 2026 at 2.70M shares.

Which other funds hold INSM?

Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Orbis Allan Gray Ltd, Darwin Global Management, Ltd., among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.